You are here

AusPAR: Sotrovimab

Australian Public Assessment Report

20 August 2021
AusPAR Details
AusPAR
Active Ingredient
Sotrovimab
Product Name
Xevudy
Sponsor
GlaxoSmithKline Australia Pty Ltd
Submission Number
PM-2021-01848-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration
AusPAR Date
20 August 2021
Publication Date

20 August 2021